Implement Adherence Programs Use technology and personal outreach to remind patients about refills and appointments
4 Thus, defects in SLC25A39 induce severe disturbances in the mitochondrial GSH-import machinery contributing to neuronal degeneration
This is particularly noticeable on the face, abdomen, thighs, and arms
A patient who begins GLP-1 therapy often experiences significant fatigue, nausea, and reduced appetite in the early weeks
Obesity: They are used as an adjunct to a reduced-calorie diet and increased physical activity to help promote weight loss in adults with a body mass index (BMI) of 30 or higher, or in adults with a BMI of 27 or higher who have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
Eligibility is determined after a thorough medical review during your virtual consultation to ensure the program is safe and appropriate for you